From
StayCurrentMD
Prevention of Parenteral Nutrition-associated Cholestasis Using Reduced Dose Soybean Lipid Emulsion: A Multicenter Randomized Trial
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Mar 2024 · 1 min read
In brief
In brief
This multicenter randomized trial investigates whether reducing soybean lipid emulsion dosage in parenteral nutrition prevents cholestasis while maintaining adequate growth and neurodevelopmental outcomes in pediatric patients. The study addresses a critical balance between preventing liver complications and ensuring sufficient nutritional support.
Written by the GCMD Library team from the article.
Reducing soybean lipid emulsion (SLE) dose may prevent parenteral nutrition-associated cholestasis (PNAC) but effects on growth and neurodevelopment are unknown. The purpose of this study was to evaluate the effect of reduced dose SLE on growth and neurodevelopment.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Intestinal Atresia Types Explained: Grossfeld Classification for Pediatric Surgery
1 min · Published Sep 2026
Video
Derivation and validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) score: A prospective cohort study
50 s · Published Sep 2026
Video
FETO for Late-Diagnosed Severe Congenital Diaphragmatic Hernia (CDH) at Cincinnati Children's with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Severe Congenital Diaphragmatic Hernia (CDH) Case: FETO Management & Unexpected Findings with Dr. Beth Rymeski
3 min · Published Sep 2026
Video
Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure: Step-by-Step Guide with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Choledochal Cyst Types Explained: Pediatric Surgery Fundamentals
1 min · Published Sep 2026
